The United States of America will allot approximately $2.03 billion for Alzheimer treatment this year.
Two thirds of the said budget will be paid for by medical institutions namely Medicare and Medicaid.
According to source, cost for Alzheimer's treatment and research will skyrocket to up to $1.21 trillion by the year 2050.
A study conducted by the National Institutes of Health (NIH) recently released their findings in the New England Journal of Medicine saying that Alzheimer's is the most expensive disease in the US, far more expensive than cancer and heart disease.
According to one researcher, if treatment for Alzheimer's will be found in the next five years, medical expenditures in the US will also drop down.
In line with this, Medicare showed their support in helping researchers find the most amiable cure by providing ample coverage for each patient.
Medicare is also supporting the suggestions of the National Alzheimer's Plan. The latter introduced the Health, Outcomes, Planning and Education (HOPE) legislation in Congress recently.
The said coverage will provide diagnosis, care planning, medical documentation and treatments for Alzheimer's patients in the next couple of years.
According to sources, Alzheimer's cases will increase to 15 million by 2050 which is a cause for alarm.
Gary Wicklund, board member of the Alzheimer's Association in East Central Iowa, now is a critical time for all Alzheimer's patients. The additional $100 million for research, education, caregiver support and outreach will really be a great help.